Healthy Microbiota Avoiding Fractures during Ageing
This project aims to identify gut microbiota signatures linked to age-related bone and muscle loss to develop novel fracture prevention therapies for the elderly.
Projectdetails
Introduction
The basic research problem: Gradual loss of bone and muscle mass with ageing leads to increased risk of fractures in the elderly population. There is a large medical need for new fracture preventive therapies with minimal side effects and novel biomarkers that improve the prediction of fracture risk. The aim of the proposed research is to test our hypothesis that the increased fracture risk in elderly people is caused by an age-dependent unhealthy change of the gut microbiota (GM) composition, resulting in reduced bone and muscle mass, and thereby increased fracture risk.
Methodology
We will identify age-dependent GM signatures that are causally associated with reduced bone and muscle mass and thereby increased fracture risk in elderly subjects. A major emphasis will be to determine causality of the GM using a variety of recently developed GM-related genetic instruments (for GM composition and function as well as for circulating metabolites) as exposures in 2-sample Mendelian randomization (MR).
In addition, we will use faecal microbiota transplantation (FMT) to directly determine causality of age-dependent GM alterations for reductions in bone and muscle mass. Based on this information, we will design candidate probiotic treatments and test their efficacy in mouse osteoporosis models. Finally, we will determine the clinical usefulness of the identified GM signatures for fracture prediction in elderly subjects.
Research Progress Beyond the State of the Art
We will employ three complementary methods:
- 2-sample MR
- FMT
- Treatment studies
These methods will help us determine causality for GM on musculoskeletal parameters. For this research, we have established large well-characterized Nordic cohorts with metagenome sequence data and information on incident fractures available in 2023.
Identification of a GM signature with a robust effect on age-related bone and muscle loss will open up completely new avenues to avoid fractures in the elderly.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.993 |
Totale projectbegroting | € 2.499.993 |
Tijdlijn
Startdatum | 1-3-2024 |
Einddatum | 28-2-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- GOETEBORGS UNIVERSITETpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Microbiome-based diagnostics and therapeuticsThis project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression. | ERC Proof of... | € 150.000 | 2023 | Details |
Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modellingThis project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions. | ERC Starting... | € 1.499.323 | 2024 | Details |
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome SpeciesThis project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health. | ERC Starting... | € 1.499.980 | 2023 | Details |
Late life-applicable enhancement of longevity and fitness.This project aims to identify molecular solutions to restore adaptive stress responses and promote healthy aging in late life using multi-omics and functional tests across various model organisms. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutritionThe InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies. | ERC Consolid... | € 2.000.000 | 2025 | Details |
Microbiome-based diagnostics and therapeutics
This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.
Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling
This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species
This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.
Late life-applicable enhancement of longevity and fitness.
This project aims to identify molecular solutions to restore adaptive stress responses and promote healthy aging in late life using multi-omics and functional tests across various model organisms.
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition
The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout PreventionThis project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses. | EIC Pathfinder | € 3.765.840 | 2024 | Details |
Ontwikkelen nieuw middel voor de lokale genezing van botbreukenDit project ontwikkelt een nieuwe formulering van microspheres met groeifactoren voor Demineralized Bone Material (DBM) om de effectiviteit bij moeilijk genezende botbreuken te verbeteren. | Mkb-innovati... | € 194.500 | 2015 | Details |
A Health Technology Assessment of a breakthrough technology in the early diagnosis of Osteoporosis and other bone related diseases.The Porous solution aims to revolutionize osteoporosis diagnosis by using mobile ultrasound technology to assess cortical bone quality and fracture risk more effectively than current BMD methods. | EIC Accelerator | € 2.500.000 | 2023 | Details |
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention
This project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses.
Ontwikkelen nieuw middel voor de lokale genezing van botbreuken
Dit project ontwikkelt een nieuwe formulering van microspheres met groeifactoren voor Demineralized Bone Material (DBM) om de effectiviteit bij moeilijk genezende botbreuken te verbeteren.
A Health Technology Assessment of a breakthrough technology in the early diagnosis of Osteoporosis and other bone related diseases.
The Porous solution aims to revolutionize osteoporosis diagnosis by using mobile ultrasound technology to assess cortical bone quality and fracture risk more effectively than current BMD methods.